Effect of ?3 on ppd test

Effect of ?3 on tuberculin test of hospitalized patients in BoAli hospital- Qazvin-Iran

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015070520882N4

Enrollment

128

Registered

2015-11-27

Start date

2015-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis. Tuberculosis

Interventions

Intervention 1: Placebo. Intervention 2: ?3-tablet 1000 mg BD (2 tablet per day) for 4 days.

Placebo

Treatment - Drugs

?3-tablet 1000 mg BD (2 tablet per day) for 4 days

Eligibility

Sex/Gender

All

Age

12 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criterion: hospitalized patients in BoAli hospital- Qazvin-Iran. Exclusion criteria: lack of medication by patients; no coming to retest.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ppd. Timepoint: Third day & Seventh Day. Method of measurement: Milimeter ruler.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Narjes Arfa

Qazvin Boali hospital

narjes,arfa@gmail.com+98 28 3333 2930

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026